Swan Capital’s CONMED CNMD Stock Holding History

Swan Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$458	Hold	14	–	–	﹤0.01%	518
2026 Q1	$495	Hold	14	–	–	﹤0.01%	490
2025 Q4	$568	Hold	14	–	–	﹤0.01%	444
2025 Q3	$658	Hold	14	–	–	﹤0.01%	422
2025 Q2	$729	Hold	14	–	–	﹤0.01%	399
2025 Q1	$845	Hold	14	–	–	﹤0.01%	298
2024 Q4	$958	Hold	14	–	–	﹤0.01%	282
2024 Q3	$1.01K	Hold	14	–	–	﹤0.01%	265
2024 Q2	$970	Buy	+14	New	+$1.02K	﹤0.01%	227

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Swan Capital's CNMD Position: Q2 2026 in Review

Swan Capital held its CONMED (CNMD) position steady in Q2 2026 at 14 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Swan Capital first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.01K in Q3 2024. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Swan Capital held 14 shares of CONMED worth $458 as of Q2 2026.
Swan Capital left its CONMED share count unchanged in Q2 2026.
CONMED made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #518 holding.
Swan Capital first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
Swan Capital's CONMED position peaked at $1.01K in Q3 2024.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.